Monlumax Capsule 200 mg contains Molnupiravir, an oral antiviral medication indicated for the treatment of mild to moderate COVID-19 in adults who are at risk of progressing to severe disease. Molnupiravir is a ribonucleoside analog that works by inhibiting the replication of the SARS-CoV-2 virus, helping to reduce viral load and lower the risk of complications.

Molnupiravir acts by introducing errors into the viral RNA during replication. This process, known as viral error catastrophe, prevents the virus from multiplying effectively within the body. By interfering with viral replication at an early stage, Monlumax helps reduce disease severity and supports faster recovery when administered promptly after diagnosis.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Monlumax Capsule 200 mg is indicated for:

• Treatment of mild to moderate COVID-19 in adults

• Patients with positive SARS-CoV-2 test results

• Individuals at high risk for progression to severe COVID-19, including hospitalization or death

It is most effective when started as soon as possible after diagnosis and within the recommended timeframe from symptom onset, as advised by a registered healthcare professional.

Dosage and Administration

The recommended adult dosage is 800 mg (four 200 mg capsules) taken orally every 12 hours for 5 days. Capsules should be swallowed whole with water and may be taken with or without food.

Treatment should be initiated as soon as possible after a confirmed diagnosis of COVID-19 and within the time period specified by clinical guidelines. The full 5-day course should be completed, even if symptoms improve earlier.

Monlumax is not authorized for use in patients under 18 years of age due to potential effects on bone and cartilage growth.

Precautions and Warnings

• Not recommended during pregnancy due to potential risk to the fetus. Women of childbearing potential should use effective contraception during treatment and for the recommended period after the last dose.

• Men with partners of childbearing potential should use reliable contraception during treatment and as advised after completion.

• Not indicated for initiation in patients hospitalized due to severe or critical COVID-19.

• Safety and effectiveness have not been established in pediatric patients.

• Use with caution in patients with significant underlying medical conditions and only under medical supervision.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Monlumax is generally well tolerated. Common side effects may include:

• Diarrhea

• Nausea

• Dizziness

• Headache

Most side effects are mild to moderate and resolve without additional treatment. Any signs of allergic reaction or unusual symptoms should be reported to a healthcare provider immediately.

Storage

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Monlumax Capsule 200 mg provides a convenient oral antiviral option for eligible adults with early COVID-19 infection, helping reduce the risk of disease progression when used appropriately under medical guidance.